Can epigenetics help in the discovery of therapeutics for psychiatric disorders, especially schizophrenia?

Expert Opinion on Drug Discovery

Volumn 4, Issue 6, 2009, Pages 621-627

  Muir, Walter J ^a   McKechanie, Andrew G ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

DNA methylation; Epigenetics; Psychiatric disorder; Schizophrenia

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CANNABIS; CARBAMAZEPINE; CLOZAPINE; DIZOCILPINE; DNA; FLUOXETINE; HISTONE DEACETYLASE 1; IMIPRAMINE; LITHIUM; MICRORNA; SULPIRIDE; VALPROIC ACID;

AUTISM; BIPOLAR DISORDER; CHROMATIN STRUCTURE; DEPRESSION; DISEASE PREDISPOSITION; DNA METHYLATION; DNA SEQUENCE; DRUG MECHANISM; DRUG TARGETING; ENVIRONMENTAL FACTOR; EPIGENETICS; EPILEPSY; GENE EXPRESSION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; METHYLATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SCHIZOPHRENIA;

EID: 67649090639     PISSN: 17460441     EISSN: None     Source Type: Journal    
DOI: 10.1517/17460440902895446     Document Type: Review

References (46)

1. Van Speybroeck L. From epigenesis to epigenetics: the case of C. H. Waddington. Ann NY Acad Sci 2002;981:61-81
2. Ptak C, Petronis A. Epigenetics and complex disease: from etiology to new therapeutics. Annu Rev Pharmacol Toxicol 2008;48:257-276 •• Excellent review; if the reader wishes to know more about psychiatric epigenetics, he or she should seek out further papers by Petronis. (Pubitemid 351738154)
3. Costa E, Dong E, Grayson DR, et al. Epigenetic targets in GABAergic neurons to treat schizophrenia. Adv pharmacol 2006;54:95-117
4. Henikoff S. Nucleosome destabilization in the epigenetic regulation of gene expression. Nat Rev Genet 2008;9(1):15-26 (Pubitemid 350277297)
5. Kouzarides T. Chromatin modifications and their function. Cell 2007;128(4):693-705 • Excellent review covering in detail how chromatin is modified epigenetically. (Pubitemid 46273577)
6. Shi Y, Whetstine JR. Dynamic regulation of histone lysine methylation by demethylases. Mol Cell 2007;25(1):1-14 (Pubitemid 46049067)
7. Altar CA, Vawter MP, Ginsberg SD. Target identification for CNS diseases by transcriptional profiling. Neuropsychopharmacology 2009;34(1):18-54
8. Weake VM, Workman JL. Histone ubiquitination: triggering gene activity. Mol Cell 2008;29(6):653-663
9. Wotton D, Merrill JC. Pc2 and SUMOylation. Biochem Soc Trans 2007;35(Pt 6):1401-1404
10. Bartova E, Krejci J, Harnicarova A, et al. Histone modifications and nuclear architecture: a review. J Histochem Cytochem 2008;56(8):711-721 (Pubitemid 351991084)
11. Santos-Reboucas CB, Pimentel MM. Implication of abnormal epigenetic patterns for human diseases. Eur J Hum Genet 2007;15(1):10-17 (Pubitemid 44921660)
12. Herran A, Garcia-Unzueta MT, Amado JA, et al. Folate levels in psychiatric outpatients. Psychiatry Clin Neurosci 1999;53(4):531-533 (Pubitemid 29404178)
13. Suzuki MM, Bird A. DNA methylation landscapes: provocative insights from epigenomics. Nat Rev 2008;9(6):465-476 • Thought provoking paper that looks at methylation in the genome in more detail. Adrian Bird's other publications should be sought out and read, especially his recent work on Rett syndrome. (Pubitemid 351693975)
14. Horsthemke B, Wagstaff J. Mechanisms of imprinting of the Prader-Willi/Angelman region. Am J Med Genet A 2008;146A(16):2041-2052
15. Ruvkun G. The perfect storm of tiny RNAs. Nat Med 2008;14(10):1041-1045
16. Guil S, Esteller M. DNA methylomes, histone codes and miRNAs: tying it all together. Int J Biochem Cell Biol 2009;41(1):87-95
17. Nagano T, Mitchell JA, Sanz LA, et al. The air noncoding RNA epigenetically silences transcription by targeting G9a to chromatin. Science 2008;322(5908):1717-1720
18. Kocerha J, Faghihi MA, Lopez-Toledano MA, et al. MicroRNA-219 modulates NMDA receptor-mediated neurobehavioral dysfunction. Proc Natl Acad Sci USA 2009;106(9):3507-3512
19. Coyle JT. MicroRNAs suggest a new mechanism for altered brain gene expression in schizophrenia. Proc Natl Acad Sci USA 2009;106(9):2975-2976
20. Rare chromosomal deletions and duplications increase risk of schizophrenia. Nature 2008;455(7210):237-241
21. Kirov G, Gumus D, Chen W, et al. Comparative genome hybridization suggests a role for NRXN1 and APBA2 in schizophrenia. Hum Mol Genet 2008;17(3):458-465
22. Stefansson H, Rujescu D, Cichon S, et al. Large recurrent microdeletions associated with schizophrenia. Nature 2008;455(7210):232-236 • The findings in this and the next paper have promise to completely change our understanding of the genetics of schizophrenia.
23. Walsh T, Mcclellan JM, Mccarthy SE, et al. Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science 2008;320(5875):539-43 • See comment for [22]. (Pubitemid 351590668)
24. Marshall CR, Noor A, Vincent JB, et al. Structural variation of chromosomes in autism spectrum disorder. Am J Hum Genet 2008;82(2):477-488
25. Sebat J, Lakshmi B, Malhotra D, et al. Strong association of de novo copy number mutations with autism. Science 2007;316(5823):445-449 (Pubitemid 46651493)
26. Weiss LA, Shen Y, Korn JM, et al. Association between microdeletion and microduplication at 16p11.2 and autism. N Engl J Med 2008;358(7):667-675 (Pubitemid 351240746)
27. Veldic M, Kadriu B, Maloku E, et al. Epigenetic mechanisms expressed in basal ganglia GABAergic neurons differentiate schizophrenia from bipolar disorder. Schizophr Res 2007;91(1-3):51-61 (Pubitemid 46320884)
28. Tandon R, Keshavan MS, Nasrallah HA. Schizophrenia, "just the facts" what we know in 2008. 2. Epidemiology and etiology. Schizophr Res 2008;102(1-3):1-18 • Excellent review covering the environmental influences in schizophrenia and the key link between these and genes.
29. Murray RM, Morrison PD, Henquet C, Di Forti M. Cannabis, the mind and society: the hash realities. Nat Rev Neurosci 2007;8(11):885-895 (Pubitemid 350006219)
30. Robbe D, Montgomery SM, Thome A, et al. Cannabinoids reveal importance of spike timing coordination in hippocampal function. Nat Neuroscience 2006;9(12):1526-1533 (Pubitemid 44862661)
31. Numachi Y, Yoshida S, Yamashita M, et al. Psychostimulant alters expression of DNA methyltransferase mRNA in the rat brain. Ann NY Acad Sci 2004;1025:102-109 (Pubitemid 39643851)
32. Miller CA, Sweatt JD. Covalent modification of DNA regulates memory formation. Neuron 2007;53(6):857-869 (Pubitemid 46367557)
33. Susser E, St Clair D, He L. Latent effects of prenatal malnutrition on adult health: the example of schizophrenia. Ann NY Acad Sci 2008;1136:185-192 •• Brings together the main researchers investigating the effects of malnutrition on schizophrenia risk, a striking example of how fetal exposure can translate to mental illness risk and where epigenetics may play a key role. (Pubitemid 351862175)
34. Youngson NA, Whitelaw E. Transgenerational epigenetic effects. Annu Rev Genomics Hum Genet 2008;9:233-257
35. Siegmund KD, Connor CM, Campan M, et al. DNA methylation in the human cerebral cortex is dynamically regulated throughout the life span and involves differentiated neurons. PLoS ONE 2007;2(9):e895
36. Chong S, Vickaryous N, Ashe A, et al. Modifiers of epigenetic reprogramming show paternal effects in the mouse. Nat Genet 2007;39(5):614-622 (Pubitemid 46676114)
37. Xing Y, Shi S, Le L, et al. Evidence for transgenerational transmission of epigenetic tumor susceptibility in Drosophila. PLoS Genet 2007;3(9):1598-1606 (Pubitemid 47510253)
38. McInnis MG, McMahon FJ, Crow T, et al. Anticipation in schizophrenia: a review and reconsideration. Am J Med Genet 1999;88(6):686-693
39. Fortune MT, Kennedy JL, Vincent JB. Anticipation and CAG*CTG repeat expansion in schizophrenia and bipolar affective disorder. Curr Psychiatry Rep 2003;5(2):145-154 (Pubitemid 38899214)
40. Peters J. Prader-Willi and snoRNAs. Nat Genet 2008;40(6):688-689
41. Milutinovic S, D'Alessio AC, Detich N, Szyf M. Valproate induces widespread epigenetic reprogramming which involves demethylation of specific genes. Carcinogenesis 2007;28(3):560-571 (Pubitemid 46523352)
42. Williams RS, Cheng L, Mudge AW, Harwood AJ. A common mechanism of action for three mood-stabilizing drugs. Nature 2002;417(6886):292-295 (Pubitemid 34534711)
43. Costa E, Chen Y, Dong E, et al. GABAergic promoter hypermethylation as a model to study the neurochemistry of schizophrenia vulnerability. Exp Rev Neurother 2009;9(1):87-98
44. Cassel S, Carouge D, Gensburger C, et al. Fluoxetine and cocaine induce the epigenetic factors MeCP2 and MBD1 in adult rat brain. Mol Pharmacol 2006;70(2):487-492 (Pubitemid 44092309)
45. Tsankova NM, Berton O, Renthal W, et al. Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action. Nat Neuroscience 2006;9(4):519-525 •• Important paper: although speculative in linking animal models to mental illness, it does carefully explore epigenetic dysregulation and its rescue by psychotropic medications. This is well worth reading.
46. Muir WJ, Pickard BS, Blackwood DH. Disrupted-in-Schizophrenia-1. Curr Psychiatry Rep 2008;10(2):140-147